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Abstract
Background: Tourniquets are often used in orthopedic surgery because empirical data suggests
that they significantly reduce blood loss and transfusion requirements, facilitate the identification
of critical anatomical structures, and provide an optimum operating field. In ischemic limbs,
tourniquet inflation increases arterial pressures and results in hypoxia, acidosis, and
hyperkalemia.1-3 When a tourniquet is removed, metabolites produced from ischemic areas enter
the systemic circulation, resulting in hypotension and hypoxia. Excessive oxygen-free radicals
are produced during reperfusion and oxygenation, contributing to leucocytic activation and
endothelial damage in blood vessels.2,4 The excess oxygen-free radicals peroxide
polyunsaturated fatty acids in membrane and plasma lipoproteins and directly inhibit
mitochondrial respiratory chain enzymes, affecting major organ functions. As a result, oxygenfree radicals play a crucial role in developing significant cardiovascular complications following
reperfusion injury.1-4 These complications are especially problematic in patients with preexisting cardiovascular disease undergoing orthopedic procedures such as total knee replacement
(TKR) with tourniquet application. 5,6
Methods: An extensive search of CINAHL and MEDLINE (ProQuest) databases was undertaken
to acquire research articles evaluating the efficacy of perioperative intravenous vitamin C in
minimizing hemodynamic fluctuations caused by tourniquet-induced ischemic-reperfusion
damage.
Results: Four studies were identified as potentially relevant for analysis. The research covered in
this review addresses the mechanisms behind tourniquet-induced ischemic-reperfusion damage
and the efficacy of perioperative intravenous vitamin C in reducing hemodynamic fluctuations
and improving patient outcomes.
Keywords: tourniquet-induced ischemic reperfusion injury, orthopedic surgery, intravenous
administration of ascorbic acid, hemodynamic fluctuations.
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Purpose/PICO Clinical Questions/Objectives
PICO Question or Purpose
Population (P): In anesthesia providers
Intervention (I): Will an education module on perioperative administration of intravenous
ascorbic acid
Compare (C): In comparison to no education.
Outcomes (O): Increase knowledge and implementation of intravenous ascorbic acid
perioperative administration to attenuate tourniquet-induced hemodynamic fluctuations.
Introduction
Problem Identification
Pneumatic tourniquets are an essential part of several orthopedic surgical procedures
involving the lower limbs.1-3 The use of the tourniquet drastically decreases blood loss and
transfusion needs, enhances visualization of critical anatomical structures, and creates an
adequate surgical field.4 While appearing to be beneficial, the use of pneumatic tourniquets in
adults undergoing orthopedic surgery has been associated with an increased risk of wound
hematoma, Deep Vein Thrombosis (DVT), Myocardial Infarction (MI), Pulmonary Embolism
(PE), and excessive oxidative stress caused by ischemic reperfusion injury to the vascular
endothelium.2-4 The processes underlying tourniquet-induced Ischemic-Reperfusion Injury (IRI)
have been related to oxidative endothelial cell toxicity caused by the immense release of
Reactive Oxygen Species (ROS) following tourniquet usage.1-5 When ischemic tissues are reperfused, significant quantities of ROS results in impairment of membrane lipids, proteins, and
DNA, ensuing in necrosis and apoptotic cell death leading to organ malfunction.1-3 The
dysfunction of endothelium causes hypotension by impairing the response to endothelial-
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dependent vasodilators and vasoconstrictors. Additionally, the failure of the endothelium barrier
leads to consequent leakage of plasma fluid from the vasculature, resulting in edema,
hypovolemia, and hypotension.4-7 Edema to the organs exacerbates the difficulty of gas exchange
and oxygenation in the lungs, leading to numerous organ failures.
Recent research has indicated that ischemia/reperfusion damage caused by oxygen
exposure is related to an increased risk of arrhythmias, heart failure, cardiogenic shock, and
long-term mortality.1-3,7-9 Regardless of the advancements in the knowledge of the processes
underlying ischemia-reperfusion injury, evidence-based attenuation of ischemic injury has been
uneven and varied, particularly in terms of patient outcomes. Due to the lack of empirical
information addressing the prevention of tourniquet-induced ischemia-reperfusion damage,
anesthesia providers must study and create objective, evidence-based clinical implications that
may serve as a starting point for subsequent practice change implementation.1-2,5,9-11 The purpose
of this research is to increase clinicians' understanding of perioperative intravenous ascorbic acid
as an additional therapy to reduce blood pressure fluctuations, myocardial damage, and
arrhythmias and enhance microcirculation and neurological patient outcomes.8
Background
Tourniquets are often used in orthopedic surgery because empirical evidence indicates
that they considerably minimize blood loss and transfusion needs, enhance identification of vital
anatomical structures, and allow for an optimal operative field.4 Tourniquet inflation elevates
arterial pressures and induces hypoxia, acidosis, and hyperkalemia in ischemic limbs. When a
tourniquet is deflated, metabolites released from ischemic regions reach the systemic circulation
cause hypotension and hypoxia. As a result of reperfusion and oxygenation, an excessive amount
of oxygen free radicals is generated, resulting in leucocytic activation and endothelial damage in
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blood vessels.4 Excessive oxygen-free radicals peroxidize polyunsaturated fatty acids in
membrane and plasma lipoproteins and directly block mitochondrial respiratory chain enzymes,
impairing major organ function. Consequently, oxygen-free radicals are critical in developing
severe cardiovascular problems following reperfusion damage.4 These consequences are
particularly concerning in patients with pre-existing cardiovascular comorbidities and orthopedic
operations such as total knee replacement (TKR) with tourniquet application.5,6,11-16
Although the pneumatic tourniquet is a crucial component of many orthopedic surgical
procedures involving the lower limbs to control intraoperative bleeding and clear the surgical
area, prolonged use of tourniquets may increase the likelihood of adverse events.2 Even though
the use of pneumatic tourniquets for orthopedic surgery may seem beneficial, it has been linked
with increased incidences of Myocardial Infarction (MI), Deep Vein Thrombosis (DVT),
Pulmonary Embolism (PE), Cerebral Vascular Accident (CVA), multisystem organ dysfunction,
and increased post-operative rates of morbidity and mortality.2-5,11-14
Scope of the Problem
A patient may require lower extremity orthopedic surgery for various reasons, including a
pre-existing musculoskeletal disease, an acute traumatic incident, or most commonly,
osteoarthritis. In the United States, osteoarthritis (OA) of the knee is the primary cause of
hospitalization for individuals aged 45–84 years, accounting for 60% of adults over 65. Total
Knee Arthroplasty (TKA) successfully treats persistent knee discomfort caused by osteoarthritis.
A recent survey of Medicare beneficiaries concluded that OA is the primary diagnosis for 94
percent of all patients undergoing TKA in the United States. In 2008, the United States
conducted over 650,000 TKAs at the cost of $9 billion. This financial load will only rise in
relevance as the geriatric population grows. Furthermore, the number of TKAs conducted yearly
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in the United States will reach 3.5 million by 2030. Thus, optimizing TKA performance is
critical for both qualities of treatment and cost reduction. 3,6
According to a 2009 survey, 95% of orthopedic surgeons use a tourniquet on patients
who have been cleared of vascular disease. Despite TKA's remarkable effectiveness in relieving
knee pain caused by OA, post-operative recovery is sometimes hampered by complications
related to tourniquet usage. Studies indicate that ischemia followed by reperfusion caused by
tourniquet usage may have clinically significant consequences.1-3,7-9 Tourniquet-induced IRI can
manifest itself in regional skeletal muscle, systemic circulation, and even remote organs, all of
which can be potentially detrimental to patients.3,6
Consequences of the Problem
The processes underlying tourniquet-induced ischemic-reperfusion damage have been
related to the enormous oxidative endothelial cell toxicity that occurs due to the tourniquet's
massive release of reactive oxygen species.1-3,7-9 When large concentrations of ROS are
introduced during reperfusion, they can cause reversible or permanent injury to proteins, lipids,
and nucleic acids, resulting in endothelial dysfunction, cellular injury, and various organ
failure.1-3,7-9 Endothelial dysfunction is a common ROS-mediated complication of
ischemia/reperfusion injury and sepsis. Additionally, ROS-induced damage to the glycocalyx,
cellular membranes, and junctions results in increased permeability, leukocyte and platelet
adhesion, local promotion of inflammation and coagulation, loss of endothelial vasodilation, and
attenuation of the vascular response to vasoconstrictors.1-4,7-9 Subsequent hypotension, vascular
leakage, and microcirculatory flow degradation after reperfusion exacerbate tissue hypoxia due
to the increased oxygen diffusion distance, therefore accelerating cellular damage and organ
failure.11-17
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Knowledge Gaps
Despite significant advances in scientific understanding of the processes behind the
ischemia-reperfusion injury, the translation of research for attenuating tourniquet-induced
ischemic injury into clinical practice has been uneven and varied, particularly concerning patient
outcomes. Current research indicates that intravenous ascorbic acid treatment during surgery as
an additional therapy reduces the occurrence of fluctuations in blood pressure, arrhythmias
caused by damage to the myocardium and improve microcirculation and neurological
outcomes.8,10,16 According to the literature, administration of vitamin C intraoperatively could
help avoid and restore microcirculatory flow impairment by preventing the activation of
nicotinamide adenine dinucleotide phosphate-oxidase and inducible nitric oxide synthase,
modulation of tetrahydrobiopterin, inhibiting oxidative phosphorylation uncoupling, and
reducing superoxide and peroxynitrite development.10,11 Additionally, by maintaining cyclic
guanylate phosphatase, IV ascorbic acid can restore vascular reactivity to vasoconstrictors and
retain the endothelium barrier.10-12 Vitamin C's possible function in IRI caused by tourniquet
usage is also strengthened by data from burns, sepsis, and cardiac studies, which demonstrate
quicker healing from organ dysfunction and improved survival rates.11-15,17
Proposal Solution
Despite literature demonstrating positive outcomes, there is a lack of consensus in
published guidelines regarding the perioperative administration of intravenous ascorbic acid as a
systematic strategy for mitigating hemodynamic changes related to IRI induced by tourniquet
use.1-3,6 Owing to the lack of empirical information addressing the prevention of tourniquetinduced ischemia-reperfusion damage, anesthesia providers must study and create objective,
evidence-based clinical implications that may serve as a framework for future practice change

11
implementation.1-3,6 By educating anesthesia providers about the value and efficacy of
perioperative intravenous ascorbic acid administration, the project proposed may assist as a step
towards instituting objective, evidence-based clinical suggestions for lowering the adverse
outcomes associated with tourniquet-induced ischemic-reperfusion injury.
Rationale
Despite considerable advancements in the scientific evidence of the mechanisms behind
the ischemia-reperfusion injury, translation of research into clinical practice for attenuating
tourniquet-induced ischemic injury has been uneven and inconsistent, particularly concerning
patient outcomes. Available literature suggests that administering intravenous ascorbic acid
during surgery as an adjunctive therapy lowers the occurrence of blood pressure variations and
arrhythmias caused by myocardial injury while also enhancing microcirculation and
neurological outcomes.8,10-12
According to the literature, intraoperative vitamin C administration may help prevent and
restore microcirculatory flow impairment by inhibiting nicotinamide adenine dinucleotide
phosphate-oxidase and inducible nitric oxide synthase activation, modulating
tetrahydrobiopterin, inhibiting oxidative phosphorylation uncoupling, and reducing superoxide
and peroxynitrite formation.10,11 Additionally, IV ascorbic acid can restore vascular
responsiveness to vasoconstrictors and preserve the endothelial barrier by sustaining cyclic
guanylate phosphatase.10-12
Intravenous Vitamin C's potential role in IRI induced by tourniquet use is further
supported by data from burns, sepsis, and cardiac research, which indicate faster organ
dysfunction repair and higher survival rates.11-15 Despite favorable outcomes, there is a scarcity
of published consensus guidelines addressing intravenous ascorbic acid as a standard strategy
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for mitigating hemodynamic shifts associated with IRI produced by tourniquet usage.1-7 By
educating anesthesia providers about the value and efficacy of perioperative intravenous
ascorbic acid administration, the proposed project may pave the way for implementing
objective, evidence-based clinical recommendations to reduce the adverse outcomes associated
with tourniquet-induced ischemic-reperfusion injury.11-17
Objective
This literature review first aims to investigate available evidence and evaluate each
study’s findings on the efficacy of ascorbic acid administration in preventing tourniquetinduced oxidative injury in patients undergoing lower limb orthopedic surgery. Secondly, this
review intends to enhance the knowledge of anesthesia providers regarding the antioxidant
effects of ascorbic acid to prevent adverse hemodynamic effects associated with tourniquetinduced ischemic reperfusion injury of vascular endothelium. Such adverse effects include
hypotension, metabolic acidosis, arrhythmias, progression of atherosclerotic lesions, plaque
instability, and subsequent myocardial infarction or stroke. Finally, the third objective is to
increase the implementation of perioperative administration of intravenous ascorbic acid to
attenuate tourniquet-induced hemodynamic fluctuations and improve patient outcomes.
Methodology
Eligibility Criteria
The studies evaluated for this literature review were chosen based on the inclusion and
exclusion criteria set to discern the objectives best. Inclusion criteria included research studies
involving human participants published in peer-reviewed journals. The studies were excluded if
they were retrospective studies, descriptive articles, editorials, or case reports. Database sources
used for the research were accessed via Florida International University (FIU) library services.
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Based on the clinical question, the following search keywords were identified using the
appropriate Boolean operators and search symbols: tourniquet-induced ischemic reperfusion
injury, ischemia-reperfusion damage, coronary artery disease, orthopedic surgery, intravenous
administration of ascorbic acid, vitamin C, hemodynamic fluctuations.
Information Sources
The databases utilized for the search included Excerpta Medica Database (EMBASE),
The Cumulative Index to Nursing and Allied Health Literature (CINAHL), and MEDLINE
(ProQuest). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) further guided the literature review.
Search Strategy
With the assistance of the FIU Health Science Librarian, the key search terms were
further expanded to include: (Tourniquet-induced ischemic reperfusion injury * OR Ischemiareperfusion damage * OR Endothelium Injury*) AND (Ascorbic Acid* OR Vitamin C*) AND
(Perioperative* OR Intraoperative* OR Preoperative*) AND (Intravenous* OR "IV") AND
(Orthopedic Surgery*) AND (Lower Extremity* OR Extremity *) AND (Hemodynamic
fluctuations OR "Hypotension").
Study Selection
The initial search through database searching (CINHAL, EMBASE, and MEDLINE)
yielded 112 articles. There were 21 duplicate articles that were removed, leaving 91 total articles
for further review. Titles were further excluded if they did not meet inclusion criteria. For
example, articles that included studies not based on human participants, retrospective studies,
descriptive articles, editorials, case reports, questionnaires. An additional 75 articles were
removed. The remaining 16 articles were retrieved and sent to the citation database Covidence
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for review. Sixteen articles were reviewed and approved for a full review of the abstract. Of the
sixteen articles, ten articles met the criteria and were further analyzed by reading the full text.
Articles that were removed included those that did not meet intervention or outcome
requirements. Only the articles that met the highest level of research were chosen, leaving four
articles for summarization.
Study Characteristics
The four articles chosen for this literature review analyzed the effects of perioperative
administration of ascorbic acid on hemodynamics in patients having orthopedic surgeries. The
study by authors Mohamed et al. (2016) investigated the comparative effectiveness of ascorbic
acid to other pharmacologic interventions.7 The purpose of this comparison was to evaluate
which pharmacologic intervention proved to be most effective in reducing the effects of
tourniquet-induced ischemic reperfusion injury during lower limb surgery. The study by Lee et
al. (2010) examined the effects of high doses of vitamin C on myocardial enzymes and oxygenfree radical production after tourniquet ischemic reperfusion injury during bilateral total knee
replacement.4 Another study by Kim et al. (2008) investigates vitamin C's effect on
hemodynamics and arterial blood gas during unilateral total knee replacement. The focus of their
study was to evaluate the cytoprotective effects of vitamin C by reducing free radicals.8 The
remaining study by Behrend et al. (2019) examined the relationship between vitamin C levels
and total knee arthroplasty. The authors examined the association between perioperative vitamin
C supplementation and overall functional outcomes after total knee arthroplasty.5 All of the
studies were primarily focused on the perioperative implantation of vitamin C in patients
undergoing orthopedic surgeries that required the use of tourniquets on the lower extremities.
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Additionally, all four of the studies selected for this literature review were randomized controlled
trials that ensure the most substantial evidence level.4-5,7-8
Summary of the Literature
The four articles chosen for this literature review analyzed the effects of perioperative
administration of ascorbic acid on hemodynamics in patients having orthopedic surgeries. The
study by authors Mohamed et al. (2016) investigated the comparative effectiveness of ascorbic
acid to other pharmacologic interventions.7 The purpose of this comparison was to evaluate
which pharmacologic intervention proved to be most effective in reducing the effects of
tourniquet-induced ischemic reperfusion injury during lower limb surgery. The study by Lee et
al. (2010) examined the effects of high doses of vitamin C on myocardial enzymes and oxygenfree radical production after tourniquet ischemic reperfusion injury during bilateral total knee
replacement.4
Another study by Kim et al. (2008) investigates vitamin C's effect on hemodynamics and
arterial blood gas during unilateral total knee replacement. The focus of their study was to
evaluate the cytoprotective effects of vitamin C by reducing free radicals.8 The remaining study
by Behrend et al. (2019) examined the relationship between vitamin C levels and total knee
arthroplasty. The authors examined the association between perioperative vitamin C
supplementation and overall functional outcomes after total knee arthroplasty.5 All of the studies
were primarily focused on the perioperative implantation of vitamin C in patients undergoing
orthopedic surgeries that required the use of tourniquets on the lower extremities. Additionally,
all four of the studies selected for this literature review were randomized controlled trials that
ensure the most substantial evidence level.4-5,7-8
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Author(s)

Purpose

Kim et
al.,
(2008).8

To investigate the
effect of vitamin C
on hemodynamics
and arterial blood
gas during
unilateral total
knee replacement.8

Lee et al.,
(2018).4

To investigate the
effects of highdose vitamin C on
oxygen free radical
production and
cardiac enzymes
after tourniquet
application and
ischemiareperfusion injury
during bilateral
total knee
replacement

Methodology/
Research
Design
Randomized
Controlled Trial
(RCT) Level I
Quality B.8

Randomized,
double-blinded,
placebocontrolled
clinical trial.
Level I Quality
A.4

Intervention(s)/
Measures

Sampling/Setting

Primary Results

Relevant
Conclusions

In the vitamin C group,
patients were
administrated with
vitamin C: a priming
bolus of vitamin C 0.06
g/kg mixed with 100
ml saline infused for 20
min at 10 min before
deflation of tourniquet,
followed by vitamin C
0.02 g/kg mixed with
30 ml saline at 0.5
ml/min. In the control
group, patients were
infused with 100 ml
saline.8
In the vitamin C (VC)
group during surgery,
patients received a
priming bolus of 0.06
g/kg vitamin C with
100 ml saline followed
by 0.02 g/kg vitamin C
mixed with 30 ml
saline intravenously.
The control group
received no intraoperative vitamin C.4
Blood samples for
arterial blood gas and

Mean arterial blood
pressure, heart rate, and
arterial blood gas were
measured at 20 min after
anesthesia induction, just
before deflation, 5 min
after deflation, and 20
min after deflation of
tourniquet.8
Sample sizes for the VC
group: N = 19, and
control group: N = 15.8

Mean arterial blood
pressure in the VC
group was maintained
higher than the control
group at 1 min after
deflation of the
tourniquet. Arterial O2
tension and saturation
in the VC group were
higher than the control
group at 5 min and 20
min after deflation of
the tourniquet.8

The study concluded
that the
administration of
vitamin C during
total knee
replacement could
significantly inhibit
the decline of mean
arterial blood
pressure and arterial
oxygenation induced
by ischemiareperfusion.8

Patients aged 65 – 75
years who underwent
bilateral TKR in hospital
settings between June
2008 and July 2009 were
randomly enrolled in this
study. Patients included
in the study had to have
American Society of
Anesthesiologists
physical status I or II and
were randomly assigned
either to receive
intraoperative high-dose

In the VC group,
malondialdehyde
levels were lower, and
arterial oxygen tension
and mean blood
pressure were higher
than in controls after
post-operative
deflation of both knee
tourniquets. Troponin
I levels were lower in
the VC group than in
controls eighth hours
postoperatively.4

Administering highdose vitamin C
during bilateral TKR
prevents oxygen-free
radical production
and a decline in
arterial oxygen
tension and mean
blood pressure
induced by ischemiareperfusion injury,
thereby protecting
the myocardium.4
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(TKR) in elderly
patients.4

Mohamed To investigate and
compare the
et al.
7
effects of
(2016).
perioperative

Randomized,
double-blinded,
placebocontrolled

MDA analysis were
obtained at the
following time points:
20 min after the
induction of anesthesia;
prior to deflation of the
first and second
tourniquets; at 5 min
after deflation of the
first and second
tourniquets; and at 20
min after deflation of
the first and second
tourniquets. Mean
arterial pressure and
heart rate, as well as
arterial oxygen tension
(PaO2), arterial carbon
dioxide tension
(PaCO2), and oxygen
saturation levels of the
cardiac enzymes
creatine
phosphokinasemyocardial band (CPKMB) and troponin I
was measured at 20
min following
anesthetic induction.4
A total of 60 patients
scheduled for unilateral
lower extremity
surgery with a

vitamin C (VC group) or
not to receive vitamin C
(control group). In total,
32 patients were enrolled
in the study: 16 in the VC
group and 16 in the
control group.4

Sixty patients ASA
physical status I or II,
aged 25–45 years,
scheduled for unilateral

Levels of MDA, IL-6,
and IL-8 were
significantly increased
in group C after

Findings concluded
that both N-acetyl
cysteine and ascorbic
acid reduce post-
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Behrend
et al.,
(2019).5

intravenous
infusion of Nacetyl cysteine and
ascorbic acid on
malondialdehyde
(MDA) production
as a marker of
oxidative stress
and IL-6 and IL-8
as markers of
systemic
inflammation after
ischemicreperfusion as
primary `
outcomes. Both
agents were
compared
regarding postdeflation
hemodynamic
effects and postdeflation changes
in arterial pH and
lactic acid as
secondary
outcomes.7
To determine
whether
perioperative
supplementation of
vitamin C (VC)
improves range of

clinical trial.
Level I Quality
B.7

pneumatic tourniquet
were included. Baseline
collection of blood
samples was done, and
then patients were
randomly classified
into three groups:
Group A; received 1 g
Ascorbic acid, group
N; received 10 mg/kg
NAC and group C
(control group):
received 100 ml saline
infusion. Two blood
samples were drawn at
each assessment time.
One sample for arterial
blood pH and lactic
acid measurement and
the other blood sample
was centrifuged and
stored at −20 °C for
subsequent analysis of
MDA, IL-6, and IL-8.7

lower extremity surgery
with a pneumatic
tourniquet for 60–90 min,
were included in this
study. With each group:
N = 20.7

tourniquet release
compared with the
baseline. In groups A
and N, MDA did not
increase over baseline
values, but IL-6 and
IL-8 levels were
increased, and their
levels were
significantly less than
in the control group.
Changes in
hemodynamics, pH,
and serum lactate were
more evident in group
C than groups A and
N.7

deflation increase in
blood levels of
oxidative stress
markers and markers
of systemic
inflammation. Thus,
both are beneficial in
preventing posttourniquet deflation
ischemic reperfusion
injury in lower limb
surgery.7

Single-center,
double-blind,
randomized,
placebocontrolled

Ninety-five patients
undergoing TKA were
randomized to either
Vitamin C (VC)
administration or
placebo (48 VC group,

Ninety-five patients aged
≥ 18 years undergoing
TKA for advanced knee
osteoarthritis (grade 3 or
4 osteoarthritides
according to Kellgren–

ROM at one year was
not different between
study groups. The
prevalence of AF was
5 of 48 (10.4%) in the
VC group compared to

The study concluded
that TKA results in
VC depletion.
Perioperative VC
supplementation
prevents VC
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motion (ROM) and study. Level I
reduces the risk of Quality B.5
arthrofibrosis (AF)
following total
knee arthroplasty
(TKA).5

47 placebo group). The Lawrence) were
effect of VC
recruited. 48= VC group,
supplementation was
47 =placebo group.5
tested on ROM, AF,
WOMAC, FJS-12, and
VC plasma
concentrations. VC
concentrations were
analyzed in both patient
groups before surgery,
4 and 7 days after
surgery.5

11 of 47 (23.4%) in
the placebo group (p =
0.09). VC
concentrations
decreased postoperatively in the
placebo group (49–12
µmol/l on day 7, p <
0.001) but not in the
VC group (53–57
µmol/l). Patients with
a perioperative drop of
VC concentrations ≥
30 µmol/l developed
significantly more AF
at one year than
patients with VC
concentrations drop of
< 30 µmol/l (p =
0.007).5

concentrations drop
in most patients
undergoing TKA and
may lower the
incidence of AF. The
clinical relevance of
this study is that VC
supplementation
seems to be a cheap
and safe adjunct to
improve functional
outcomes after
TKA.5
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Systematic Review
In the study by Kim et al. (2008), the authors wanted to investigate the effect of vitamin
C on hemodynamics and arterial blood gas during unilateral total knee replacement.8 The authors
designed the study to evaluate several parameters: blood pressure, mean arterial pressure, arterial
oxygen partial pressure, and oxygen saturation.8 The patients were randomly divided into the
vitamin C group and a controlled group. In the vitamin C group (VC group: N = 19), patients
were administrated a priming bolus of vitamin C 0.06 g/kg mixed with 100 ml saline infused for
20 min at 10 min before deflation of tourniquet, followed by vitamin C 0.02 g/kg mixed with 30
ml saline at 0.5 ml/min. In the control group (control group: N = 15), patients were infused with
100 ml saline.8 The authors excluded patients who were pharmacotherapies such as beta-blockers
and vasodilators. Patients with a history of previous myocardial infarction and kidney or ureter
stones were also excluded from this study. To ensure the most consistent analysis of parameters,
the mean arterial blood pressure, heart rate, and arterial blood gas were measured at 20 min after
anesthesia induction, just before deflation, 5 min after deflation, and 20 min after deflation of
tourniquet.8
All statistical analyses were performed using the SPSS® statistical package, version 14.0
(SPSS Inc., Chicago, IL, USA) for Windows®. Data are shown as mean ± SD. Differences in
demographics and baseline clinical characteristics between the two groups, including age,
weight, hypertension, and hemoglobin level, were analyzed using the Student’s t-test.8 Betweengroup differences in arterial blood gas and hemodynamic profiles were analyzed using a repeated
measure analysis of variance (ANOVA) with adjustments for age, diabetes mellitus, and
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hemoglobin status. A P-value < 0.05 was considered to be statistically significant.8 Upon
analysis, there was no significant difference in the tourniquet time between the two groups. The
data analysis revealed that the mean arterial pressure was significantly higher in the VC group
than in the control group at 5 minutes after decompression of the tourniquet. Mean arterial
pressure in the controlled group was significantly reduced 5 minutes after tourniquet
decompression compared from the values just before deflation to low (P < 0.05).8 There was no
difference in the pulse rate between the VC group and the controlled group. In both groups, the
analysis of arterial blood gas showed the pH measured after anesthesia was significantly reduced
at 5 and 20 minutes after tourniquet decompression. After tourniquet decompression in the
control group at 5 min, arterial oxygen partial pressure and saturation significantly decreased (P
< 0.05). In comparison, at 5 and 20 minutes after tourniquet decompression, the arterial oxygen
partial pressure and oxygen saturation were higher in the VC group with a significant increase (P
< 0.05).8
The authors concluded that the mean arterial blood pressure in the VC group was
maintained higher than the control group at 1 min after deflation of the tourniquet. Furthermore,
the study results demonstrated that the arterial oxygen partial pressure and saturation in the VC
group were higher than the control group at 5 min and 20 min after deflation of the tourniquet.
The authors determined that during unilateral total knee replacement among the elderly, the
administration of intravenous vitamin C could significantly prevent the decline of mean arterial
blood pressure and arterial oxygenation induced by ischemia-reperfusion injury.8
While in the study conducted by Kim et al. (2008), the authors wanted to investigate the
effect of vitamin C on hemodynamics and arterial blood gas, Lee et al. (2018) explored the effect
of high-dose vitamin c on oxygen free radical production and myocardial enzyme after
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tourniquet ischemia-reperfusion injury during bilateral total knee replacement.4 The authors
designed a randomized, double-blinded, placebo-controlled clinical trial to examine if high dose
vitamin C during the perioperative period could reduce the effects of ischemic-reperfusion injury
associated with pneumatic tourniquets.4 To examine these effects of vitamin C, the authors
measured the levels of Malondialdehyde (MDA), a biomarker for oxidative stress, and levels of
cardiac enzymes creatine phosphokinase-myocardial band (CPK-MB) and troponin I. Patients
aged 65 – 75 years who underwent bilateral TKR in hospital settings between June 2008 and July
2009 were randomly enrolled in this study. Patients included in the study had to have American
Society of Anesthesiologists physical status I or II and were randomly assigned either to receive
intraoperative high-dose vitamin C (VC group) or not to receive vitamin C (control group).4 The
exclusion criteria were myocardial ischemia or a history of uncontrolled hypertension, or the
presence of diarrhea or renal calculus. In total, 32 patients were enrolled in the study: 16 in the
VC group and 16 in the control group. In the vitamin C (VC) group (VC group, n = 16), during
surgery, patients received a priming bolus of 0.06 g/kg vitamin C with 100 ml saline followed by
0.02 g/kg vitamin C mixed with 30 ml saline, intravenously. The control group (n = 16) received
no intra-operative vitamin C.4
Blood samples for arterial blood gas and MDA analysis were obtained at the following
time points: 20 min after the induction of anesthesia; before deflation of the first and second
tourniquets; at 5 min after deflation of the first and second tourniquets; and at 20 min after
deflation of the first and second tourniquets.4 Mean arterial pressure and heart rate, as well as
arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), and oxygen saturation
levels of the cardiac enzymes creatine phosphokinase-myocardial band (CPK-MB) and troponin
I were measured at 20 min following anesthetic induction. This study assumed a mean difference
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and standard deviation of MDA of 0.7 and 0.7, respectively. As a result, assuming a withdrawal
rate of 10%, it was estimated that 16 patients in each group would be needed to provide the study
with a statistical power of 80% and a significance level of 0.05 to detect clinically meaningful
differences between the control the VC group.4
All statistical analyses were performed using the SPSS® statistical package, version 14.0
(SPSS Inc., Chicago, IL, USA) for Windows®. Data are shown as mean ± SD. Differences in
demographics and baseline clinical characteristics between the two groups, including age,
weight, hypertension, and hemoglobin level, were analyzed using the Student’s t-test.4 Betweengroup differences in arterial blood gas, hemodynamic profile, and MDA level were analyzed
using a repeated measure analysis of variance (ANOVA) with adjustments for age, diabetes
mellitus, and hemoglobin status. Within-group time-dependent differences in these parameters
were also compared using ANOVA. Analyses of CPK-MB and troponin I levels were performed
using analysis of covariance. A P value < 0.05 was considered to be statistically significant.4
The authors did not find any significant between-group differences in demographics and
baseline clinical characteristics upon analyzing the data. Comparing both groups, at 5 min after
deflation of both the first and second tourniquets, the serum levels of MDA were significantly
lower in the VC group compared with the control group (P < 0.05). Within the VC group, there
were no significant differences in MDA levels at any time point. In the control group, serum
MDA levels increased significantly at 5 and 20 min after deflation of the first tourniquet
compared with at 20 min after the induction of anesthesia, i.e., before deflation of the tourniquet
(P < 0.05).4 In addition, compared with serum MDA levels observed prior to deflation of the
second tourniquet, serum MDA levels were significantly increased 5 min after deflation of the
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second tourniquet (P < 0.05). A significant decrease in serum MDA levels was also observed at
20 min compared with 5 min after the deflation of the second tourniquet (P < 0.05).4
While evaluating hemodynamic, the authors found that mean arterial pressure was
significantly lower at 5 min after the first tourniquet deflation in the control group as compared
with the VC group (P < 0.05), but following deflation of the second tourniquet, no significant
differences were observed between the two groups.4 In the VC group, CPK-MB levels were
decreased at eight hours post-operation compared with levels observed in the control group, but
the difference was not statistically significant. Troponin I levels were significantly lower at eight
hours post-operation in the VC group than in the control group (P < 0.05).4
The study concluded that administering high-dose vitamin C to elderly patients
undergoing bilateral TKR surgery could lower MDA levels and prevent the unstable
hemodynamics and hypoxia caused by ischemia-reperfusion injury in both knees.4 As a result,
the myocardium could be protected more effectively. Particularly in elderly patients with
concurrent severe pulmonary or cardiac disease, administering high-dose vitamin C intraoperatively might, therefore, decrease both cardiopulmonary complication and mortality rates.4
Both studies were done by Kim et al. (2008), and Lee et al. (2010) investigated the
effects of vitamin C as the sole intervention. The authors of Mohamed et al. (2016) designed a
double-blind, randomized, placebo-controlled clinical trial to compare two different
pharmacologic interventions.7 The study investigated and compared the effects of perioperative
intravenous infusion of N-acetyl cysteine and ascorbic acid on malondialdehyde (MDA)
production as a marker of oxidative stress and IL-6 and IL-8 as markers of systemic
inflammation after ischemic-reperfusion as primary outcomes.7 Additionally, the authors
compared both agents concerning post-deflation hemodynamic effects and post-deflation
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changes in arterial pH and lactic acid as secondary outcomes.7 In this study, 60 patients were
included with an ASA physical status I or II, aged 25–45 years, scheduled for unilateral lower
extremity surgery with a pneumatic tourniquet for 60–90 minutes. Exclusion criteria included the
presence of vascular disease, cardiorespiratory disease, renal insufficiency, liver dysfunction,
diabetes, or the administration of any antioxidant or anti-inflammatory drug.7
Baseline collection of blood samples was done, and then patients were randomly
classified into three groups: Group A; received 1 g Ascorbic acid, group N; received 10 mg/kg
NAC and group C (control group): received 100 ml saline infusion. Each group had 20
participants within their perspective group.7 Two blood samples were drawn at each assessment
time at baseline (T0), 1 min after tourniquet placement (T1), 1 min before tourniquet release
(T2), 5 min after tourniquet release (T3), 20 min ATR (T4), and one-hour ATR (after tourniquet
release) (T5). One sample was for arterial blood pH and lactic acid measurement, and the other
blood sample was centrifuged and stored at −20 °C for subsequent analysis of MDA, IL-6, and
IL-8.7
Statistical analysis was done using GraphPad© Prism© for Windows© version 6 and
GraphPad© Instat© version 3.05 (GraphPad Software, Inc., San Diego California, USA).7 It was
estimated that a sample of 20 patients per group would have a power of 86% to detect a large
effect size of (f = 0.45) as regards the primary outcome (production of malondialdehyde, IL-6,
and IL-8) measures using the F-test and assuming a two-sided type I error of 0.05. Continuous
numerical variables were presented as mean (SD), and intergroup comparisons were made using
one-way analysis of variance (ANOVA) with the use of the Tukey–Kramer test for post hoc
comparisons. Discrete variables were presented as median (interquartile range), and the Kruskal–
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Wallis test was used to compare the groups. Categorical data were presented as a ratio or as
number (%), and the Pearson chi-square test was used to test between-group differences.7
The data revealed that Levels of MDA, IL-6, and IL-8 were significantly increased in
group C after tourniquet release compared with the baseline. 7 MDA levels did not increase over
baseline values in groups A and N, but IL-6 and IL-8 levels were increased, and their levels were
significantly less than in the control group.7 Changes in hemodynamics, pH, and serum lactate
were more evident in group C than groups A and N. The study results allowed the authors to
conclude that both N-acetyl cysteine and ascorbic acid reduce post-deflation increase in blood
levels of oxidative stress markers and systemic inflammation markers. Thus, both are beneficial
in preventing post-tourniquet deflation ischemic reperfusion injury in lower limb surgery.7
The study by Behrend et al. (2019) examined the relationship between vitamin C levels
and total knee arthroplasty.5 The authors designed this study to determine whether perioperative
supplementation of vitamin C (VC) improves range of motion (ROM) and reduces the risk of
arthrofibrosis (AF) following total knee arthroplasty (TKA).5 The trial was designed as a singlecenter, double-blind, randomized, placebo-controlled study. Ninety-five patients undergoing
TKA were randomized to either Vitamin C administration or placebo (48 VC group, 47 placebo
group). The effect of VC supplementation was tested on ROM, AF, WOMAC, FJS-12, and VC
plasma concentrations analyzed in both patient groups before surgery, 4 and 7 days after
surgery.5
Fasting vitamin C plasma concentration was analyzed preoperatively and on postoperative days 4 and 7. Complete Vitamin C plasma levels were available for a total of 75
patients. 5 Patients were stratified into groups with and without VC drop, depending on whether
the perioperative VC plasma concentration dropped ≥ 30 or < 30 µmol/l from pre-operative to
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post-operative day 7. The rationale for this threshold was the rounded difference from average (>
50 µmol/l) to hypovitaminosis C (< 23 µmol/l).5 The primary outcome parameter was knee joint
ROM over the first post-operative year as measured with a goniometer by a trained study nurse
blinded to the research history. In all cases, knee joint ROM was assessed preoperatively, at eight
weeks and 12 months post-operatively. Secondary endpoints included the incidence of AF,
patient-reported outcome measures, and the VC plasma concentration. 5
All TKAs (cemented LCS® complete™ low contact stress complete knee system, Leeds,
UK, DePuy Synthes) were performed with a computer-assisted ligament balancing technique
(Vector Vision, CT-free, optoelectronic, passive marker navigation system, Brain-Lab, Munich,
Germany) using a medial parapatellar approach with a tourniquet. 5 A uniform pain relief
protocol was used in all patients postoperatively.5 Rehabilitation consisted of continuous passive
motion in the hospital, ROM exercises instructed by physiotherapists, and two crutches for six
weeks with full weight-bearing as tolerated. Patient-reported outcome (PRO) was evaluated
using the WOMAC score and the Forgotten Joint Score-12 (FJS-12). Descriptive statistics
included medians, standard deviations, ranges, and proportions. Comparative statistics included
unpaired t-tests and Chi-square test (where appropriate, Fisher's exact test was alternatively
applied). The confidence level for rejecting null hypotheses was set at 95% (p-value < 0.05).5
The data from the study proposed that ROM at one year was not different between study
groups. The prevalence of AF was 5 of 48 (10.4%) in the VC group compared to 11 of 47
(23.4%) in the placebo group (p = 0.09).5 Interestingly, this study found that VC plasma
concentrations decreased post-operatively in the placebo group (49–12 µmol/l on day 7, p <
0.001), but not in the VC group (53–57 µmol/l).5 Furthermore, patients with a perioperative drop
of VC plasma concentration of ≥ 30 µmol/l developed significantly more AF at one year than
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patients with a VC plasma concentration drop of < 30 µmol/l (p = 0.007).5 The authors
concluded that total knee arthroplasty does result in depletion of vitamin C plasma
concentrations.5 Moreover, the data determined that perioperative VC supplementation prevents
VC plasma concentration drop in most patients undergoing TKA and may lower the incidence of
AF. The clinical relevance of this study is that VC supplementation seems to be a cheap and safe
adjunct to improve functional outcomes after TKA.5
Discussion
Tourniquets are often used in orthopedic surgery because empirical evidence indicates
that they considerably minimize blood loss and transfusion needs, enhance identification of vital
anatomical structures, and allow for an optimal operative field.1-5 Tourniquet inflation elevates
arterial pressures and induces hypoxia, acidosis, and hyperkalemia in ischemic limbs. When a
tourniquet is deflated, metabolites released from ischemic regions reach the systemic circulation
cause hypotension and hypoxia.1-5 As a result of reperfusion and oxygenation, excessive oxygen
free radicals are generated, resulting in leucocytic activation and endothelial damage in blood
vessels.4-7 Consequently, oxygen-free radicals are critical in developing severe cardiovascular
problems following reperfusion damage.4 These consequences are particularly concerning in
patients with pre-existing cardiovascular comorbidities and orthopedic operations such as total
knee replacement (TKR) with tourniquet application.1-5
Current research indicates that intravenous ascorbic acid treatment during surgery as an
additional therapy reduces the occurrence of fluctuations in blood pressure, arrhythmias caused
by damage to the myocardium and improve microcirculation and neurological outcomes.8,10,16
For instance, the study conducted by Kim et al. (2008) investigated the effect of vitamin C on
hemodynamics and arterial blood gas during unilateral total knee replacement.8 The study
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determined that the mean arterial blood pressure for patients who were administered intravenous
vitamin C during the intraoperative period was maintained higher than the control group at 1 min
after deflation of the tourniquet.8 Additionally, the results also demonstrated that patients given
intravenous vitamin C had higher arterial oxygen partial pressure and saturation than the control
group at 5 min and 20 min after deflation of the tourniquet.8
The excessive oxidative stress caused by the deflation of the pneumatic tourniquet can
potentially damage many organs throughout the body, including the heart.4 In the study by Lee et
al. (2018), the authors examined the effect of high-dose vitamin c on oxygen-free radical
production and myocardial enzyme after tourniquet ischemia-reperfusion injury during bilateral
total knee replacement. The authors designed a double-blinded study to evaluate how
intraoperative treatment of high dose vitamin C would influence Malondialdehyde (MDA), a
biomarker for oxidative stress, and levels of cardiac enzymes creatine phosphokinase-myocardial
band (CPK-MB) and troponin I.4 The results from the study concluded that administering highdose vitamin C to elderly patients undergoing bilateral TKR surgery could lower MDA levels
and prevent the unstable hemodynamics and hypoxia caused by ischemia-reperfusion injury in
both knees.4 Hence, showcasing that high dose vitamin C during the intraoperative period could
have myocardium protective effects, particularly in elderly patients with concurrent severe
pulmonary or cardiac disease.1-4
With the possible positive outcomes of perioperative ascorbic acid in mind, the authors of
Mohamed et al. (2016) pursued to compare the different pharmacologic interventions to manage
oxidative stress caused by the tourniquet released during orthopedic surgeries.7 Their study
investigated and compared the effects of perioperative intravenous infusion of N-acetyl cysteine
and ascorbic acid on malondialdehyde (MDA) production as a marker of oxidative stress and IL-
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6 and IL-8 as markers of systemic inflammation after ischemic-reperfusion.7-10 Additionally, the
authors evaluated the serum lactate and pH levels in all of the groups in the study. The data
analysis showed that patients who did not receive any intervention had significantly higher levels
of MDA, IL-6, and IL-8 after tourniquet release compared with the baseline.7 In comparison,
patients given a perioperative intravenous infusion of N-acetyl cysteine and ascorbic acid had no
increase in the MDA levels compared to baseline values. Furthermore, the changes in
hemodynamics, pH, and serum lactate were more evident in the control group compared to the
intervention groups.7
Lastly, in their study, Behrend et al. (2019) analyzed the relationship between vitamin C
levels and total knee arthroplasty.5 The authors investigated whether perioperative
supplementation of vitamin C (VC) improves range of motion (ROM) and reduces the risk of
arthrofibrosis (AF) following total knee arthroplasty (TKA).5 Interestingly, the researchers
determined that total knee arthroplasty results in depletion of vitamin C plasma concentrations.5
In addition, the data established that perioperative VC supplementation prevents VC plasma
concentration drop in most patients undergoing TKA and may lower the incidence of AF.5 The
findings of these studies help support that perioperative intravenous vitamin C should be utilized
routinely for patients undergoing orthopedic surgeries in which a pneumatic tourniquet may be
employed to minimize IRI injuries and achieve optimal outcomes.4-6,7-8
Conclusion
Despite considerable improvements in scientific understanding of the mechanisms behind
the ischemia-reperfusion injury, translation of research into clinical practice for attenuating
tourniquet-induced ischemic injury has been uneven and inconsistent, particularly concerning
patient outcomes. This research indicates that administering intravenous ascorbic acid during
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surgery as an adjunctive therapy minimizes the occurrence of blood pressure variations and
arrhythmias caused by myocardial injury while also enhancing microcirculation and neurological
outcomes.8,10,16 According to the literature, intraoperative vitamin C administration may help
prevent and restore microcirculatory flow impairment by inhibiting nicotinamide adenine
dinucleotide phosphate-oxidase and inducible nitric oxide synthase activation, modulating
tetrahydrobiopterin, inhibiting oxidative phosphorylation uncoupling, and reducing superoxide
and peroxynitrite formation.10,11 Additionally, IV ascorbic acid can restore vascular
responsiveness to vasoconstrictors and preserve the endothelial barrier by sustaining cyclic
guanylate phosphatase.10-12 Vitamin C's potential role in IRI produced by tourniquet use is
supported by data from burns, sepsis, and cardiac investigations, demonstrating faster healing
and increased survival rates following organ failure.10-11 13-17
There is a lack of consensus published guidelines regarding the perioperative
administration of intravenous ascorbic acid as a systematic strategy for mitigating hemodynamic
changes related to IRI induced by tourniquet use despite literature demonstrating positive
outcomes. Owing to the lack of guidelines for preventing tourniquet-induced ischemiareperfusion damage, anesthesia providers must utilize evidence-based research to drive their
clinical interventions to minimize IRI injuries and achieve optimal outcomes.1-3,15-17 By
educating anesthesia providers about the value and efficacy of perioperative intravenous ascorbic
acid administration, the project proposed may assist as a step towards instituting objective,
evidence-based clinical suggestions for lowering the adverse outcomes associated with
tourniquet-induced ischemic-reperfusion injury.
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Organizational Assessment
Implementing the evidence-based guideline for perioperative intravenous ascorbic acid
will be conducted within a collaborative team approach. We will first determine the steps
needed to develop the evidence-based guideline for perioperative intravenous ascorbic acid. A
flowchart will be formed to represent the visualization of the process steps. Data can be
analyzed and compared with the goals and expectations devised during the planning phase
through chart reviews of hemodynamic fluctuations pre-and post- perioperative intravenous
ascorbic acid implementation. In the evaluation phase, the anesthesia providers will be
interviewed to input the program’s overall effectiveness. Additionally, the interdisciplinary
team will be expected to present a summary of the program's significant findings. The report
must be concise and include a description of the program, the interventions used, a purpose
statement, the methods used for data collection and analysis, which should include the
background and history of the clinical issues, the tools used to collect information, and how data
was analyzed, significant findings and conclusions, unexpected and unanticipated outcomes,
design flaws, and recommendations to improve the program.
Primary DNP Project Goal
A pneumatic tourniquet is an integral component of many orthopedic surgical procedures
of the lower extremities.1-3 While beneficial at first sight, the use of pneumatic tourniquet in
patients undergoing orthopedic surgery has also been associated with increased long-term
mortality, systolic and diastolic heart failure, cardiogenic shock, myocardial stunning, and
arrhythmias.1-6 Despite the growing understanding of the mechanisms of ischemia-reperfusion
injury, the translation of evidence into clinical practice for attenuation of tourniquet-induced
ischemic injury has been inconsistent and variable, particularly concerning patient outcomes.

Page 32 of 72

33
According to current studies, perioperative intravenous administration of ascorbic acid as an
adjunct treatment has shown to attenuate incidences of blood pressure fluctuations, myocardial
injury, arrhythmias and improves microcirculation and neurological patient outcomes.7-9
Literature suggests that intraoperative infusion of vitamin C can prevent
"microcirculatory flow impairment by inhibiting activation of nicotinamide adenine dinucleotide
phosphate-oxidase and inducible nitric oxide synthase, augmenting tetrahydrobiopterin,
preventing uncoupling of oxidative phosphorylation, and decreasing the formation of superoxide
and peroxynitrite, and by directly scavenging superoxide".7-9 Additionally, IV administration of
ascorbic acid can also restore vascular responsiveness to vasoconstrictors and preserve
endothelial barrier by maintaining cyclic guanylate phosphatase.1-6,9-11 Based on the common
pathophysiological pathways, the potential role of vitamin C for tourniquet-induced ischemiareperfusion injury is further supported by the results of sepsis, burns, and cardiac studies,
showing earlier recovery from organ failure and higher survival rates.1-5,7-12
Despite literature demonstrating the positive outcomes of intravenous administration of
ascorbic acid, published consensus guidelines have not yet included its implementation as a
standard intervention for preventing the hemodynamic fluctuations associated with tourniquetinduced ischemic reperfusion injury.1-5,7-12 Anesthesia providers possess the ability to intervene
and reduce hemodynamic fluctuations caused by tourniquet-induced ischemic reperfusion injury
by incorporating perioperative intravenous administration of ascorbic acid.1-5,7-9 Hence, there is a
need for educational evidence-based recommendations on dealing with this common
phenomenon to reduce variations in practice. The primary goal of developing an evidence-based
recommendation regarding the use of perioperative ascorbic acid is to provide all anesthesia
providers a guideline for managing hemodynamic fluctuations when taking care of patients
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undergoing orthopedic surgery using a pneumatic tourniquet. The recommendation's objective is
to re-examine traditional practices and replace them with evidence-based guidelines to reduce the
effects caused by tourniquet-induced ischemic reperfusion injury.
Goals and Outcomes
To guide the development of the goal objectives, the acronym SMART was utilized.
SMART details that the objectives should be specific, measurable, achievable, realistic, and
timely.18
Specific
Anesthesia providers will have a standardized, evidence-based recommendation of
perioperative intravenous administration of ascorbic acid protocol for hemodynamic
management of patients undergoing orthopedic surgery using a pneumatic tourniquet.
Measurable
The effectiveness of the educational program of utilizing perioperative administration of
ascorbic acid will be calculated by analyzing a questionnaire that will be provided to participants
before and after an educational intervention. Outcomes will be measured by evaluating the
variations in providers’ knowledge of tourniquet induced ischemic reperfusion injury, the
consequences of reperfusion injury on organ systems, pharmacodynamic properties of ascorbic
acid, the available recommendation for managing oxidative stress, and the effectiveness of
ascorbic acid to manage oxidative stress caused by tourniquet release pre-and post-intervention.
In order to generate reports, Qualtrics® software will be used to create the surveys and analyze
data.
Achievable
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Anesthesiologists, Certified Registered Nurse Anesthetists, Anesthesiologist Assistants,
Pharmacists, Orthopedic and trauma surgeons would collaborate to develop an evidence-based
guideline for perioperative intravenous ascorbic acid use.
Realistic
Anesthesia providers and surgeons who perform orthopedic surgeries requiring a
pneumatic tourniquet will be educated on the benefits of utilizing perioperative infusion of
ascorbic acid. Facility informatics will collaborate with pharmacies and providers to develop an
electronic order set for easy access.
Timely
All anesthesia providers are educated through an online education module presented
through a Voiceover PowerPoint presentation on implementing an evidence-based algorithm and
pamphlets given to those who cannot attend. All staff will be aware of the background of the
problem, evidence-based supporting practice change, and the practice change suggestion within a
6-month time frame. The outcome of this initiative will be as follows: within six months, all
anesthesia providers will be able to discuss hemodynamic fluctuations associated with
tourniquet-induced ischemic reperfusion injury and when to initiate IV administration of Vitamin
C in orthopedic procedures.
Program Structure
Developing an evidence-based guideline for perioperative intravenous ascorbic acid use
will require a collaborative, multidisciplinary team effort. A comprehensive assessment will be
performed to identify opportunities and the importance, value, and significance of the project to
all stakeholders.13 The strength, weakness, opportunities, and threats (SWOT) analysis
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assessment tool will be utilized to evaluate the internal and external characteristics and threats to
the program’s development.
The project aims to determine the anesthesia providers’ knowledge of using perioperative
ascorbic acid to manage hemodynamic fluctuations when taking care of patients undergoing
orthopedic surgery using a pneumatic tourniquet. The expert stakeholders of this project are the
anesthesia providers and orthopedic surgeons who will guide the development of an evidencebased guideline for perioperative intravenous ascorbic acid and the providers’ educational
intervention. The participants will first be provided with a questionnaire to measure their
knowledge of tourniquet induced ischemic reperfusion injury, the consequences of reperfusion
injury on organ systems, pharmacodynamic properties of ascorbic acid, the available
recommendation for managing oxidative stress, and the effectiveness of ascorbic acid to manage
oxidative stress caused by tourniquet release. Participants will then be provided with an
educational course addressing the use of perioperative ascorbic acid for managing hemodynamic
fluctuations when taking care of patients undergoing orthopedic surgery using a pneumatic
tourniquet. This course will be provided to all anesthesia providers and surgeons through a
Clinical Site Presentation on implementing an evidence-based algorithm, and pamphlets will be
given to those who cannot attend. After the intervention, participants will be asked to take a
survey to analyze the variations in their knowledge before and after the educational course.
Strengths
In the United States, osteoarthritis (OA) of the knee is the primary cause of
hospitalization for individuals aged 45–84 years, accounting for 60% of adults over 65.6 Total
Knee Arthroplasty (TKA) successfully treats persistent knee discomfort caused by osteoarthritis.
A recent survey of Medicare beneficiaries concluded that OA is the primary diagnosis for 94
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percent of all patients undergoing TKA in the United States.6 In 2008, the United States
conducted over 650,000 TKAs at the cost of $9 billion. This financial load will only rise in
relevance as the geriatric population grows.6
Furthermore, the number of TKAs conducted yearly in the United States will reach 3.5
million by 2030. Thus, optimizing TKA performance is critical for both qualities of treatment
and cost reduction.3,6 Developing an evidence-based guideline for perioperative intravenous
ascorbic acid can improve patient outcomes and increase patient satisfaction and overall
experience. Additionally, another major strength of this project is that there are minimal side
effects and contraindications. Furthermore, the low cost of intravenous ascorbic acid
administration is also appealing for facilities when incorporating a new practice change.6
Weakness
As Moran et al. (2020) defined, the plan’s weaknesses are any internal issues that may be
damaging to the program.13 An internal problem identified is the lack of pre-existing suggestions
to use as a guidance tool while developing new recommendations for implementation at the
facility. Furthermore, the lack of sufficient knowledge regarding the tourniquet induced ischemic
reperfusion injury, the consequences of reperfusion injury on organ systems, pharmacodynamic
properties of ascorbic acid, the available recommendation for managing oxidative stress, and the
effectiveness of ascorbic acid to manage oxidative stress caused by tourniquet release can also
present as a weakness. Another weakness of the proposed project can come from the surgeon’s
preference regarding their preferred method of patient care. Orthopedic surgeons may have other
preferences for their patients and may be resistant to incorporating new practices. These
preferences can make implementing the proposed recommendation of intravenous ascorbic acid
difficult for anesthesia providers.
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Opportunities
Implementing an evidence-based guideline for perioperative intravenous ascorbic acid
can collaborate with other disciplines such as orthopedic surgeons and trauma teams. There is a
high prevalence of geriatric patients undergoing orthopedic procedures in lower extremities,
which further serves as an opportunity for implementing the recommended use of perioperative
intravenous ascorbic acid. Additionally, the recommendation of intravenous ascorbic acid serves
as an inexpensive intervention change for the facility with the possibility of improved patients'
outcomes, increased patient satisfaction, and overall experience
Threats
Factors that may potentially harm the process or interfere with the program’s ability to
achieve its objectives must be evaluated.13 Risks to the program may include the anesthesia
providers’ negative feelings towards the perioperative intravenous ascorbic acid use because of
the deviation from the current standard of care. These negative feelings can present as a lack of
participation and cooperation from anesthesia providers. The orthopedic surgical team may also
be unwilling to participate in the practice change due to similar feelings. Because the successful
implementation of an evidence-based guideline for the perioperative intravenous ascorbic acid
program is heavily dependent on provider compliance, surgeons and anesthesia providers must
feel a vested interest in the process and indicate their agreement to engage in a new protocol
different from current perioperative management.
Conceptual Underpinning and Theoretical Framework of the Project
The theoretical framework serves as a guide or can be thought of as a road map for the
DNP project. The conceptual framework establishes the actions and foundations for the
technique used in the DNP project.13 Lewin's Change Theory will be the basis for this DNP
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project. Unfreezing, change, and refreezing are the three stages in Lewin's approach.19 The
unfreezing stage provides an awareness of the need for change, which is subsequently
evaluated.19 Recognizing the repercussions of tourniquet-induced ischemia-reperfusion damage
would necessitate a change. The second stage is to ascertain where change is required and
where it is already occurring.19 The second stage would be for changes to the protocol or
processes, such as intravenous ascorbic acid. The third and final stage, refreezing, occurs once
equilibrium has been achieved and lasting alteration has transpired.19 Refreezing or integrating
the project would require establishing standards to minimize hemodynamic changes in patients
undergoing orthopedic surgery using a pneumatic tourniquet. Lewin's Change Theory provides
a framework for companies to identify and acknowledge the possibility of change, examine
feasible modifications, and finally execute the policy or behavior changes.19 Additionally,
Lewin's Change Theory aids change agents in overcoming resistance and promoting the
adoption of best practices in healthcare.19
Methodology
Setting and Participants
Proper implementation of this quality improvement project requires a group of study
participants to receive an educational presentation on the anesthetic implications of tourniquetinduced ischemic reperfusion injury. The primary setting of this quality improvement project
will take place at a significant, level 1 trauma center in southwest Florida. Primary participants
include all anesthesia providers employed at this facility. The participants will be recruited
voluntarily, and the anticipated sample size will be between 5-15 participants.
The principal methodology of the proposed project is to administer an online educational
presentation to anesthesia providers encompassing the anesthetic implications of tourniquet-

Page 39 of 72

40
induced ischemic reperfusion injury. Participants will first complete an online pre-intervention
test, evaluating current knowledge of tourniquet-induced ischemic reperfusion injury.
Participants will then be given a 10-minute online educational presentation on tourniquetinduced ischemic reperfusion injury, the use of intra-operative use of intravenous ascorbic acid,
and related anesthetic implications. Participants will then be evaluated on knowledge gained as
evidenced by a post-intervention test.
Results obtained in the post-intervention test will provide feedback regarding the impact
of the educational presentation. The pre/post-testing provides relevant information regarding the
efficacy of the educational presentation and seeks to improve anesthetic care of patients
undergoing orthopedic surgeries of the lower extremities. Outcomes will also demonstrate if
additional anesthesia provider education is needed.
Protection of Human Subjects
The recruitment population will include anesthesia providers at a level 1 trauma center in
southwest Florida for this quality improvement project. This population is significant because
they deliver anesthesia care to patients undergoing orthopedic surgeries of the lower extremities.
Participant recruitment will be conducted via email invitation to all anesthesia providers at this
location. Participation will be voluntary with no penalty for withdrawing withdraw from the
project. There are no perceived risks to the study as it only requires the time spent by each
participant in the education intervention.
Data Collection
Data collection will include a pre-and post-test to determine the effects of the educational
intervention. Both assessments will be conducted using surveys consisting of approximately ten
questions focusing on knowledge and practice using Qualtrics. The pre-test will assess

Page 40 of 72

41
knowledge of tourniquet-induced ischemic reperfusion injury and associated anesthetic
implications, while the post-test survey will determine if the participants gained knowledge from
the intervention. The instrument reliability and validity will be measured in accordance with the
intervention provided and its effectiveness for the participants. The data collected will be
confidential, and no subject identifiers will be recorded during any study component.
Data Management and Analysis Plan
The DNP student will be responsible for administering the pre-test, educational
intervention, and post-test. Results will be kept using Microsoft Excel software and only
accessible to the DNP student and FIU faculty members. This data will be stored on a passwordprotected computer, ensuring confidentiality. Pre- and post-test results will be recorded to
identify knowledge bases before and after the educational intervention. Statistical analysis will
be performed to determine the effectiveness of the educational presentation and its impact on the
anesthesia provider.
Results
Pre/Post-Test Demographics
The pre-test demographics are represented below in Table 2.
Table 2. Pre/Post-Test Demographics
Consent – I consent to participate.
#

Answer

%

Count

1

Yes

100.00%

7

2

No

0.00%

0

Total

100%

7

Q1 – Please indicate the gender you identify as.
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#

Answer

%

Count

1

Male

57.14%

4

2

Female

42.86%

3

3

Non-binary

0.00%

0

4

Prefer not to answer

0.00%

0

Total

100%

7

Q2 – Please indicate your age.
#

Answer

%

Count

1

25-35

42.86%

3

2

36-45

14.29%

1

3

46-55

28.57%

2

4

56-65

0.00%

0

5

>65

14.29%

1

Total

100%

7
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Q3 – Please indicate your ethnicity.
#

Answer

%

Count

1

Hispanic

42.86%

3

2

Caucasian (non-Hispanic)

28.57%

2

3

African American

14.29%

1

4

Asian

0.00%

0

5

Other

14.29%

1

Total

100%

7

Q4 – Please indicate your highest education level.
#

Answer

%

Count

1

Associates

0.00%

0

2

Bachelors

0.00%

0

3

Masters

28.57%

2

4

Doctorate

71.43%

5

5

Others

0.00%

0

Total

100%

7
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Q5 – Please indicate the numbers of years that you have been an anesthesia provider.
#

Answer

%

Count

1

Less than 5 years

57.14%

4

2

5-10

14.29%

1

3

10-15

0.00%

0

4

Greater than 15

28.57%

2

Total

100%

7

There was a total of seven participants completed the study in its entirety. The pre-test
demographics represented the following participant gender identities, female (n = 3; 42.8%), and
male (n= 4, 57.1%). Various ethnicities were also represented among the participants, with the
majority being Hispanic (n = 3, 42.8%), followed by Caucasian (n = 2; 28.5%), African
American (n = 1; 14.2%), and Other (n = 1; 14.2%). There was a vast age range of participants
with ages 25 to 35 years old (n = 3; 42.8%), 36 to 45 years old (n = 1; 14.2%), 46 to 55 years old
(n = 2; 28.5%), and greater than 65 years old (n = 1; 14.2%). A vast majority of participants held
a Doctorate degree (n = 5; 71.4%), followed by a Master’s degree (n = 2; 28.5%). Lastly, all
participants were asked how many years they have been an anesthesia provider; 0 to 5 years (n =
4; 57.1%), 6 to 10 years (n = 1; 14.2%), and greater than 15 years (n = 2; 28.5%).
Pre-Test Identification of Knowledge on Pneumatic Tourniquet and Use of Intravenous
Ascorbic Acid to Attenuate Hemodynamic Fluctuations
The pre-test consisted of ten questions that assessed current knowledge on pneumatic
tourniquets and the use of intravenous ascorbic acid to attenuate hemodynamic fluctuations.
100% (n = 7) of the participants correctly identified the benefits of utilizing pneumatic
tourniquets for orthopedic surgeries. 87.5 (n = 6) of the participants correctly identified the
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physiologic effects of inflating the pneumatic tourniquet. Similarly, 87.5 (n = 6) of the
participants correctly identified the effects caused by metabolites produced from the ischemic
area entering systemic circulation upon deflating the pneumatic tourniquet. 71.4% (n = 5) of the
participants correctly identified that excessive oxygen-free radicals are produced during
reperfusion and oxygenation, which contributes to leucocytic activation and endothelial damage
in blood vessels. A total of 71.4% (n = 5) of the participants correctly identified the increased
incidence of events associated with the use of a pneumatic tourniquet. The participants selected
57.1% (n = 4) always, 28.6% (n = 2) most of the time, 14.3% (n = 1) sometimes, to altering their
anesthetic plan for orthopedic surgery when their patient has cardiopulmonary comorbidities.
None of the participants identified utilizing intravenous ascorbic acid infusion during their
anesthetic management for orthopedic surgeries involving a pneumatic tourniquet. Most
participants, 71.4% (n = 5), could identify that intravenous ascorbic can be utilized
intraoperatively for its antioxidant properties to attenuate hemodynamic fluctuation caused by
oxygen-free radicals. Only four participants (n = 4, 57.1%) correctly identified the antioxidant
effects of ascorbic acid had been shown to reduce intraoperative variations in hemodynamics and
incidences of arrhythmias. Correspondingly, four participants (n = 4, 57.1%)
correctly identified that incorporating high-dose ascorbic acid administration intraoperatively has
myocardium protective effects for patients with concurrent severe pulmonary or cardiac disease.
Post-Test Identification of Knowledge on Pneumatic Tourniquet and Use of Intravenous
Ascorbic Acid to Attenuate Hemodynamic Fluctuations
After the voiceover PowerPoint presentation, all the areas except two illustrated an
increase in knowledge compared to baseline knowledge on the topics. There was a significant
increase of 100% in participant response to utilizing intravenous ascorbic acid infusion during
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your anesthetic management for orthopedic surgeries involving a pneumatic tourniquet in the
future. Two other content areas showed a 42.9% increase in the knowledge rates on identifying
the correct antioxidant and myocardium protective effects of ascorbic acid for patients with
concurrent severe pulmonary or cardiac disease.
Three content areas illustrated a 28.6% increase in knowledge compared to baseline.
These areas include correctly identifying that excessive oxygen-free radicals are produced during
reperfusion and oxygenation, recognizing which events have increased incidences with the use of
a pneumatic tourniquet and that intravenous ascorbic can be utilized intraoperatively for its
antioxidant properties to attenuate hemodynamic fluctuation caused by oxygen-free radicals.
Two content areas demonstrated a 14.3% increase in knowledge on identifying physiologic
effects of inflating the pneumatic tourniquet and the effects caused by metabolites produced from
the ischemic area entering systemic circulation upon deflating the pneumatic tourniquet. The two
content areas that did not show any increase in knowledge were correctly identifying the benefits
of utilizing pneumatic tourniquets for orthopedic surgeries and the frequency of providers
altering their anesthetic management for orthopedic surgery when your patient has
cardiopulmonary comorbidities. Table 3 below highlights the pre-test and post-test differences in
responses.
Table 3. Difference in Pre-test and Post-test Knowledge
Question

Pre-test

Post-test

Difference

What are the benefits of utilizing pneumatic
tourniquets for orthopedic surgeries?

100% (n = 7)

100% (n = 7)

0%

Inflation of pneumatic tourniquet results in
what physiologic effects?

85.7% (n = 6)

100% (n = 7)

14.3%
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Upon deflation of the pneumatic tourniquet,
the metabolites produced from ischemic area
enter systemic circulation and produce what
effects?

85.7% (n = 6)

100% (n = 7)

14.3%

During reperfusion and oxygenation, what is
produced which contributes to leucocytic
activation and endothelial damage in blood
vessels?

71.4% (n = 5)

100% (n = 7)

28.6%

Pneumatic tourniquet use is associated with
increased incidences of which of the
following?

71.4% (n = 5)

100% (n = 7)

28.6%

Intravenous ascorbic can be utilized
intraoperatively for its antioxidant properties
to attenuate hemodynamic fluctuation caused
by oxygen-free radicals.

71.4% (n = 5)

100% (n = 7)

28.6%

The antioxidant effects of ascorbic acid have
shown to reduce intraoperative variations in
hemodynamics and incidences of arrhythmias

57.1% (n = 4)

100% (n = 7)

42.9%

Incorporating high-dose ascorbic acid
57.1% (n = 4)
administration intraoperatively has
myocardium protective effects for patients
with concurrent severe pulmonary or cardiac
disease.
Have you/would you ever utilized intravenous 0% (n = 7)
ascorbic acid infusion during your anesthetic
management for orthopedic surgeries
involving a pneumatic tourniquet?
How frequent do you change your anesthetic
57.1% (n = 4)
plan for orthopedic surgery when your patient
has cardiopulmonary comorbidities?

100% (n = 7)

42.9%

100% (n = 7)

100%

57.1% (n = 4) 0%

Summary of Data
Overall, the results demonstrated an increase in knowledge rates between the pre-test and
post-tests, except for correctly identifying the benefits of utilizing pneumatic tourniquets for
orthopedic surgeries and the frequency of providers altering their anesthetic management for
orthopedic surgery when your patient has cardiopulmonary comorbidities, which yielded a 0%
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difference. There was a substantial increase of 100% in participant response to utilizing
intravenous ascorbic acid infusion during your anesthetic management for orthopedic surgeries
involving a pneumatic tourniquet in the future. Furthermore, other content areas showed a
noteworthy increase of 42.9 % in the knowledge rates on identifying the correct on identifying
the correct antioxidant and myocardium protective effects of ascorbic acid for patients with
concurrent severe pulmonary or cardiac disease. Graph 1 below illustrates the individual pre-test
and post-test results of each question.
Graph 1. Individual Pre-test and Post-test Results

What are the benefits of utilizing pneumatic tourniquets
for orthopedic surgeries:
8
6
4
2
0
Decreased blood loss

Enhanced visualization of
anatomical structures
Pre-Test

Decreased Transfusion
requirements

All of the above

Post-Test

Inflation of pneumatic tourniquet results in what
physiologic effects:
8
6
4
2
0
Decreased arterial
pressures

Increased arterial
pressures

Hypokalemia

Pre-Test

Post-Test
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Upon deflation of the pneumatic tourniquet, the
metabolites produced from ischemic area enter systemic
circulation and produce what effects:
8
6
4
2
0
Hypoxia and Hypotension

Hyperoxia and Hypertension
Pre-Test

Post-Test

During reperfusion and oxygenation, what is produced
which contributes to leucocytic activation and
endothelial damage in blood vessels:
8
6
4
2
0
Excessive oxygen-free radicals

Excessive carbon dioxide-free radicals
Pre-Test

Post-Test

Pneumatic tourniquet use is associated with increased
incidences of which of the following:
8
6
4
2
0
Myocardial Infarction (MI)

Deep Vein Thrombosis
(DVT)
Pre-Test

Pulmonary Embolism (PE)
Post-Test
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Intravenous ascorbic can be utilized intraoperatively for
its antioxidant properties to attenuate hemodynamic
fluctuation caused by oxygen-free radicals:
8
6
4
2
0
Pre-Test

Post-Test
TRUE

FALSE

The antioxidant effects of ascorbic acid has shown to
reduce intraoperative variations in hemodynamics and
incidences of arrhythmias:
8
6
4
2
0
Pre-Test

Post-Test
TRUE

FALSE

Incorporating high-dose ascorbic acid administration
intraoperatively has myocardium protective effects for
patients with concurrent severe pulmonary or cardiac
disease:
8
6
4
2
0
Pre-Test

Post-Test
TRUE

FALSE

Neither True or False
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Have you/would you ever utilize intravenous ascorbic
acid infusion during your anesthetic management for
orthopedic surgeries involving a pneumatic tourniquet:
8
6
4
2
0
Yes

No
Pre-Test

Post-Test

How frequently do you change your anesthetic plan for
orthopedic surgery when your patient has
cardiopulmonary comorbidities:
5
4
3
2
1
0
Always

Most of the time

Sometimes

Pre-Test

Never

Post-Test

Discussion
Limitations
This study had several limitations, including a small sample size and the length of time
required for participants to complete the study. Out of the 34 emails sent to anesthesia providers
from the ANESCO anesthesia group at Broward Health Medical Center, only seven participants
completed the pre-test and post-test survey. A larger and more diverse sample size would have
reflected a more accurate representation of the knowledge base on the care of the transgender
patient population and the need for education. Furthermore, participants were given a limited
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time of two weeks to complete the education module, and an extended time frame may have
increased the response rate.
Future Implications for Advanced Nursing Practice
The increasing use of pneumatic tourniquets for orthopedic surgeries has also increased
the possibility of tourniquet-induced ischemic reperfusion injury. Despite new research,
insufficient knowledge exists regarding the pharmacodynamic benefits of ascorbic acid for
managing oxidative stress caused by tourniquet-induced ischemic reperfusion injury. The
developed and implemented educational module for this study demonstrated an increase in
knowledge rate compared to baseline knowledge rates in all areas except for two. There were no
increases in knowledge of correctly identifying the benefits of utilizing pneumatic tourniquets for
orthopedic surgeries and the frequency of providers altering their anesthetic management for
orthopedic surgery when your patient has cardiopulmonary comorbidities. The data showed that
the educational module effectively increased healthcare providers' knowledge and confidence in
using intravenous ascorbic acid as an available recommendation for managing oxidative stress.
Anesthesia providers need to understand the possible implications of poorly managed oxidative
stress relating to anesthetic management. Furthermore, it is imperative to stay informed with
current research on this topic, and more research will need to be conducted to provide safe,
quality patient care.
Conclusion
There is a lack of consensus published guidelines regarding the perioperative
administration of intravenous ascorbic acid as a systematic strategy for mitigating hemodynamic
changes related to IRI induced by tourniquet use despite literature demonstrating positive
outcomes. Owing to the lack of guidelines for preventing tourniquet-induced ischemiaPage 52 of 72
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reperfusion damage, anesthesia providers must utilize evidence-based research to drive their
clinical interventions to minimize IRI injuries and achieve optimal outcomes. Educational
interventions such as this quality improvement project can effectively increase provider
knowledge and the likelihood of utilizing current evidence-based research to provide safe,
quality care and improve overall patient outcomes.
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Appendix B: QI Project Consent

CONSENT TO PARTICIPATE IN A QUALITY IMPROVEMENT PROJECT
“Efficacy Of Intravenous Ascorbic Acid for Attenuating Hemodynamic Fluctuations Associated with
Tourniquet-Induced Ischemic Reperfusion Injury in Patients Undergoing Lower Extremity Orthopedic
Surgery”

SUMMARY INFORMATION
Things you should know about this study:








Purpose: Educational module regarding the efficacy of intravenous ascorbic acid for
attenuating hemodynamic fluctuations associated with tourniquet-induced ischemic reperfusion
injury in patients undergoing lower extremity orthopedic surgery.
Procedures: Participate in a pre-test, view an Educational Module via voice over PowerPoint,
then participate in a post test
Duration: This will take about a total of 20 minutes.
Risks: The main risk or discomfort from this research is minimal
Benefits: The main benefit to you from this research is increase the participant’s knowledge of
intravenous ascorbic acid for attenuating hemodynamic fluctuations associated with tourniquetinduced ischemic reperfusion injury in patients undergoing lower extremity orthopedic surgery.
Alternatives: There are no known alternatives available to you other than not taking part in
this study.
Participation: Taking part in this research project is voluntary.

Please carefully read the entire document before agreeing to participate.

PURPOSE OF THE PROJECT
The goal of this project is to improve health care provider knowledge regarding the efficacy of
intravenous ascorbic acid for attenuating hemodynamic fluctuations associated with
tourniquet-induced ischemic reperfusion injury in patients undergoing lower extremity
orthopedic surgery. You are being asked to participate in this quality improvement project
DURATION OF THE PROJECT
Your participation will require about 20 minutes of your time, you will be one of 10 people in
this study
PROCEDURES
If you agree to be in the project, we will ask you to do the following things: Participate in a
pretest view, an Educational Module via voice over PowerPoint, then participate in a post test.
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RISKS AND/OR DISCOMFORTS
Minimal risk, risk not greater than if participant was conducting similar activity. Physical,
psychological, social, legal, and economic risks minimal and no greater than if a participant was
participating in a similar activity. Similar activity such as filling out an online survey and
watching voice over PowerPoint.
BENEFITS
The following benefits with your participation in this project: An increase in your knowledge
of intravenous ascorbic acid for attenuating hemodynamic fluctuations associated with
tourniquet-induced ischemic reperfusion injury in patients undergoing lower extremity
orthopedic surgery.
ALTERNATIVES
There are no known alternatives available to you other than not taking part in this project.
However, if you would like to receive the educational material given to the participants in this
project, it will be provided to you at no cost.
CONFIDENTIALITY
The records of this project will be kept private and will be protected to the fullest extent
provided by law. If, in any sort of report, we might publish, we will not include any
information that will make it possible to identify you as a participant. Records will be stored
securely, and only the project team will have access to the records.

PARTICIPATION: Taking part in this research project is voluntary.
COMPENSATION & COSTS
There is no cost or payment to you for receiving the health education and/or for participating in
this project.
RIGHT TO DECLINE OR WITHDRAW
Your participation in this project is voluntary. You are free to participate in the project or
withdraw your consent at any time during the project. Your withdrawal or lack of participation
will not affect any benefits to which you are otherwise entitled. The investigator reserves the
right to remove you without your consent at such time that they feel it is in the best interest.
RESEARCHER CONTACT INFORMATION
If you have any questions about the purpose, procedures, or any other issues relating to this
research project, you may contact Bilal Mohammad at 954-512-0276, bmoha008@fiu.eduj or Dr.
Jorge Valdes at 305-348-7729/jvalde@fiu.edu.
IRB CONTACT INFORMATION
If you would like to talk with someone about your rights pertaining to being a subject in this
project or about ethical issues with this project, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu.
PARTICIPANT AGREEMENT
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I have read the information in this consent form and agree to participate in this study. I have had
a chance to ask any questions I have about this study, and they have been answered for me. By
clicking on the “consent to participate” button below I am providing my informed consent.
(Insert Consent to Participate Button Here on the Website)
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Appendix C: Recruitment Letter
Efficacy of Intravenous Ascorbic Acid in Attenuating Hemodynamic Fluctuations
Associated with Tourniquet-Induced Ischemic Reperfusion Injury in Patients Undergoing
Lower Extremity Orthopedic Surgery: A Quality Improvement Project

Dear Broward Health ANESCO anesthesia provider,
My name is Bilal Mohammad, and I am a student from the Anesthesiology Nursing Program
Department of Nurse Anesthetist Practice at Florida International University. I am writing to
invite you to participate in my quality improvement project. The goal of this project is to
improve health care provider knowledge on efficacy of intravenous ascorbic acid in attenuating
hemodynamic fluctuations associated with tourniquet-induced ischemic reperfusion injury in
patients undergoing lower extremity orthopedic surgery. You are eligible to take part in this
project because you are an anesthesia provider at Broward Health.
If you decide to participate in this project, you will be asked to complete and sign a consent form
for participation. Next, you will complete a pre-test questionnaire, which is expected to take
approximately 5 minutes. You will then be asked to view an approximately 15-minute-long
educational presentation online. After watching the video, you will be asked to complete the
post-test questionnaire, which is expected to take approximately 5 minutes. No compensation
will be provided.
Remember, this is completely voluntary. You can choose to be in the study or not. If you'd like
to participate or have any questions about the study, please email or contact me at
bmoha008@fiu.edu or 954-512-0276.
Thank you very much.
Sincerely,
Bilal Mohammad
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Appendix D: Letter of Support
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Appendix E: Pretest and Posttest Questionnaire

Pretest and Posttest Questionnaire:
An Educational Module Highlighting the Efficacy of Intravenous Ascorbic Acid in
Attenuating Hemodynamic Fluctuations Associated with Tourniquet-Induced Ischemic
Reperfusion Injury in Patients Undergoing Lower Extremity Orthopedic Surgery: A
Quality Improvement Project
INTRODUCTION
The primary aim of this QI project is to improve the knowledge of anesthesia providers
regarding the management of tourniquet induced ischemic reperfusion injury and the efficacy of
intravenous ascorbic acid.
Please answer the question below to the best of your ability. The questions are either in
multiple choice or true/false format. These questions are meant to measure knowledge,
perception, and understanding of tourniquet induced ischemic reperfusion injury, the associated
effects and the efficacy of intravenous ascorbic acid.
PERSONAL INFORMATION
1. Gender
a. Male
b. Female
c. Non-binary
d. Prefer not to answer
2. Age in years
a. 25-35
b. 36-45
c. 46-55
d. 56-65
e. > 65
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3. Ethnicity:
a. Hispanic
b. Caucasian (non-Hispanic)
c. African American
d. Asian
e. Other
4. Position/Title
a. Certified Registered Nurse Anesthetist
b. MD anesthesia
5. Highest level of education
a. Associates
b. Bachelors
c. Masters
d. Doctorate
e. Other
6. Years of practice as an anesthesia provider
a. Less than 5
b. 5-10
c. 10-15
d. Greater than 15
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QUESTIONNAIRE
1. What are the benefits of utilizing pneumatic tourniquets for orthopedic surgeries?
a. Decreased blood loss
b. Enhanced visualization of anatomical structures
c. Decreased Transfusion requirements
d. All of the above
2. Inflation of pneumatic tourniquet results in what physiologic effects?
a. Decreased arterial pressures
b. Increased arterial pressures
c. Hypokalemia
d. Alkalosis
3. Upon deflation of the pneumatic tourniquet, the metabolites produced from ischemic area
enter systemic circulation and produce what effects?
a. Hypoxia and Hypotension
b. Hypertension and Hyperoxia
4. During reperfusion and oxygenation, what is produced which contributes to leucocytic
activation and endothelial damage in blood vessels?
a. Excessive oxygen-free radicals
b. Excessive carbon dioxide-free radicals
5. Pneumatic tourniquet use is associated with increased incidences of which of the
following?
a. Myocardial Infarction (MI),
b. Deep Vein Thrombosis (DVT)
c. Pulmonary Embolism (PE)
d. All of the above
6. Intravenous ascorbic can be utilized intraoperatively for its antioxidant properties to
attenuate hemodynamic fluctuation caused by oxygen-free radicals.
a. True
b. False
7. The antioxidant effects of ascorbic acid has shown to reduce intraoperative variations in
hemodynamics and incidences of arrhythmias.
a. True
b. False
8. Incorporating high-dose ascorbic acid administration intraoperatively has myocardium
protective effects for patients with concurrent severe pulmonary or cardiac disease.
a. True
b. False
9. Have you ever utilized intravenous ascorbic acid infusion during your anesthetic
management for orthopedic surgeries involving a pneumatic tourniquet?
a. Yes
b. No
10. How frequent do you change your anesthetic plan for orthopedic surgery when your
patient has cardiopulmonary comorbidities?
a. Always
b. Often
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c. Sometimes
d. Never
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Appendix F: QI Educational Module
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